Deryabin P G, Garaev T M, Finogenova M P, Botikov A G, Shibnev V A
D. I. Ivanovskii Research Institute of Virology, Ministry of Health and Social Development of the Russian Federation, Moscow, Russia.
Bull Exp Biol Med. 2014 May;157(1):62-5. doi: 10.1007/s10517-014-2492-2. Epub 2014 Jun 10.
We studied the capacity amino acid derivatives of adamantane to inhibit replication of highly virulent avian influenza A/duck/Novosibirsk/56/05 (H5N1) virus in cultures of swine embryonic kidney cells. Amino acid derivatives of adamantane H-His-Rem and Ad(CH2-Ser-OMe)2 were characterized by lower toxicity than remantadine previously used in the treatment of influenza. Histidine-containing adamantane derivative (H-His-Rem) was the most effective and low-toxic inhibitor of influenza А/H5N1 virus replication and can be recommended for clinical trials to produce a preparation for the treatment and prevention of influenza.
我们研究了金刚烷氨基酸衍生物抑制高致病性甲型禽流感病毒/鸭/新西伯利亚/56/05(H5N1)在猪胚胎肾细胞培养物中复制的能力。金刚烷氨基酸衍生物H-His-Rem和Ad(CH2-Ser-OMe)2的毒性低于先前用于治疗流感的金刚乙胺。含组氨酸的金刚烷衍生物(H-His-Rem)是最有效且低毒的甲型H5N1流感病毒复制抑制剂,可推荐用于临床试验,以制备治疗和预防流感的制剂。